A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

Phase 3

Completed

• Conditions: Candidiasis

• Registration Number: NCT00163111
• Lead Sponsor: Pfizer

Brief Summary

This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients

Detailed Description

Not available

Study Timeline

• Study Start: 1998-09
• Study Completion: 2003-05
• Study First Submitted: 2005-09-09
• Study First Submitted QC: 2005-09-09
• Study First Posted: 2005-09-13
• Status Verified: 2011-04
• Last Update Submitted: 2011-04-25
• Last Update Posted: 2011-04-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 412

Inclusion Criteria

• Patients with candidemia

Exclusion Criteria

• Neutropenia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Sustained clinical response for 12 weeks from end of treatment

Secondary Outcome Measures

Name	Time	Method
Time to negative blood cultures